Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study (Q43546731)

24 November 2017

title

Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study (English)

1 reference

24 November 2017

main subject

cardiovascular disease

1 reference

1 reference

24 November 2017

L A Cupples

1 reference

24 November 2017

P W Wilson

1 reference

24 November 2017

C Lahoz

1 reference

24 November 2017

E J Schaefer

1 reference

24 November 2017

D Levy

1 reference

24 November 2017

D Osgood

1 reference

24 November 2017

S Parpos

1 reference

24 November 2017

J Pedro-Botet

1 reference

24 November 2017

J A Daly

1 reference

24 November 2017

publication date

1 February 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

154

1 reference

24 November 2017

1 reference

24 November 2017

page(s)

529-537

1 reference

Familial lipoprotein disorders in patients with premature coronary artery disease

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

A receptor-mediated pathway for cholesterol homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E Alleles and Risk of Coronary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Epidemiological approaches to heart disease: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

A simple salting out procedure for extracting DNA from human nucleated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Increased frequencies of apolipoprotein epsilon 2 and epsilon 4 alleles in patients with ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Hyperlipoproteinemia as a risk factor for ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E phenotypes in patients with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E genotype and plasma levels in coronary artery disease. A case-control study in the Italian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Polymorphism of the apolipoprotein E and angiotensin I converting enzyme genes in Japanese patients with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Association of genetic polymorphisms in the ACE, ApoE, and TGF beta genes with early onset ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E genotypes in offspring with a positive and negative family history of premature myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

The relationship between risk factor levels and presence of coronary artery calcification is dependent on apolipoprotein E genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E and atherosclerosis in Alaska Natives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Lipid profiles reflecting high and low risk for coronary heart disease: contribution of apolipoprotein E polymorphism and lifestyle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Estrogen Up-regulates Apolipoprotein E (ApoE) Gene Expression by Increasing ApoE mRNA in the Translating Pool via the Estrogen Receptor α-Mediated Pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Genes, variation of cholesterol and fat intake and serum lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

The genetics of serum lipid responsiveness to dietary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Apolipoprotein E phenotype and diet-induced alteration in blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Genetic studies of human apolipoproteins. XVI. APOE polymorphism and cholesterol levels in the Mayans of the Yucatan Peninsula, Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

High frequency of the apo epsilon 4 allele in Khoi San from South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

An investigation of coronary heart disease in families. The Framingham offspring study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Polymorphism at the apoprotein-E locus in relation to risk of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900570-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(00)00570-0

1 reference

24 November 2017

1 reference